If you need more lookups,
subscriptions start at $34 USD/month.
David Boothe Location
United Kingdom
David Boothe Work
Chief Executive Officer and Co-founder @ (January 2023 - Present)
Business Unit Head - Neurological and Rare Disorders @ (August 2020 - January 2023)
Head of Europe, Rare Diseases and Endocrinology @ (May 2019 - August 2020)
Endocrinology Lead, UK and Ireland @ (May 2018 - August 2020)
Regional Commercial Head - Northern Europe @ (September 2016 - February 2018)
Global Commercial Leader @ (April 2011 - May 2016)
Product Director @ Shire HGT (November 2009 - April 2011)
Marketing Director @ (January 2004 - January 2008)
Marketing Manager @ Oxford GlycoSciences (January 2000 - January 2003)
Senior Product Manager @ (January 1997 - January 2000)
Medical Rep @ (January 1990 - January 1992)
Medicinal Chemist @ British BioTechnology (January 1987 - January 1989)
David Boothe Education
De Montfort University
Chemistry
David Boothe Skills
Biopharmaceuticals
Biotechnology
Business Development
Cardiology
Clinical Development
Clinical Trials
Commercialization
Cross-functional Team Leadership
Dermatology
Diabetes
Drug Development
Gastroenterology
Hematology
Hospital Sales
Infectious Diseases
Leadership
Life Sciences
Lifesciences
Management
Market Access
Market Analysis
Neurology
Oncology
Pharmaceutical Industry
Pharmaceutical Sales
Product Launch
Rheumatology
Sales Effectiveness
Strategic Thinking
Strategy
Team Leadership
David Boothe Summary
David Boothe, based in United Kingdom, is currently a Chief Executive Officer and Co-founder at Exert Therapeutics. David Boothe brings experience from previous roles at Orion Corporation, HRA Pharma and Spark Therapeutics, Inc.. David Boothe holds a Chemistry @ De Montfort University. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Cardiology, Clinical Development and more. David Boothe has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different David Boothe?
Find contact details for 700 million professionals.